A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study
Services
Services
Date issued
2013Journal title
Annals of the rheumatic diseases
Type of content
Publicación de congreso
